Supplemental Figures for "Cancer and Healthcare Reform: Making the Pieces Fit"

Publication
Article
OncologyONCOLOGY Vol 25 No 9
Volume 25
Issue 9

Note:These supplemental figures provide concrete illustrations of a number of the authors’ points.

Articles in this issue
Management of DCIS-A Work in Progress
Tailored Strategies for DCIS Management
Neuroendocrine Tumors: a Heterogeneous Set of Neoplasms
Surgical Management of Neuroendocrine Tumors of the Gastrointestinal Tract
Can We Know What to Do When DCIS Is Diagnosed?
A Rare Case of Metastatic Renal Epithelioid Angiomyolipoma
The Changing Field of Locoregional Treatment for Breast Cancer
Surgical Management of Neuroendocrine Tumors: Treatment of Localized and Metastatic Disease
Cancer and Healthcare Reform: Making the Pieces Fit
Cancer and Healthcare Reform: Making the Pieces Fit
An Approach to the Management of Rare Tumors
Supplemental Figures for "Cancer and Healthcare Reform: Making the Pieces Fit"
Malignant Angiomyolipoma: a Rare Entity With Unusual Biology
Locoregional Treatment of Breast Cancer: Where to Next?
Progress but Not Perfection: Ongoing Efforts to Optimize Locoregional Treatments for Breast Cancer
Mangosteen (Garcinia mangostana)
Mangosteen (Garcinia mangostana)
Recent Videos
Related Content
Analyzing Long-Term Follow-Up Results From MonumenTAL-1 in Multiple Myeloma

Analyzing Long-Term Follow-Up Results From MonumenTAL-1 in Multiple Myeloma

ONCOLOGY Staff
August 17th 2025
Article

Experts discussed talquetamab's unique mechanism and favorable patient outcomes in relapsed/refractory multiple myeloma.

Stem Cell Transplant Approaches for Patients With Blood Cancers

Stem Cell Transplant Approaches for Patients With Blood Cancers

David T. Scadden, MD
March 13th 2019
Podcast

Dr. Scadden discusses which blood cancer patients are eligible for stem cell transplantation, as well as the latest advances in the field.

Safeguarding Vulnerability: COVID-19’s Impact on Immunocompromised Patients With Cancer

Safeguarding Vulnerability: COVID-19’s Impact on Immunocompromised Patients With Cancer

Viviana Cortiana, MS4;Maduri Balasubramanian, MD;Jade Gambill, BS;Diksha Mahendru, MD;Kennedy Itodo, MD;Chandler H. Park, MD, MS, FACP;Yan Leyfman, MD
August 15th 2025
Article

Immunocompromised individuals face ongoing COVID-19 risks despite vaccination, highlighting the need for tailored public health strategies and innovative therapies.

Current Treatment of Esophageal Cancer and Promising Clinical Trials Underway

Current Treatment of Esophageal Cancer and Promising Clinical Trials Underway

Geoffrey Y. Ku, MD
March 13th 2019
Podcast

Dr. Ku discusses considerations in the treatment of esophageal cancer, current treatments, and the emerging role of immunotherapy.

A Phase 2 Study of Docetaxel and Capecitabine in Advanced Squamous Cell Carcinoma of the Head and Neck

A Phase 2 Study of Docetaxel and Capecitabine in Advanced Squamous Cell Carcinoma of the Head and Neck

Omar K. Abughanimeh, MBBS;Nicole A. Shonka, MD;Jane Meza, PhD;Lynette Smith, PhD;Irfan A. Vaziri, MD;Mehmet Sitki Copur, MD;Robin High, MBA;Kimberly Shields, BSN, RN;Holly DeSpiegelaere, BSN, RN;Anne Kessinger, MD;Apar Kishor Ganti, MD, MS
August 13th 2025
Article

This study explores the efficacy and safety of combining docetaxel and capecitabine for treating recurrent or metastatic head and neck cancer.

Obesity and weight gain are associated with adverse outcomes following breast cancer diagnosis.

GLP-1 Receptor Agonist Use and Weight Change in Patients With Breast Cancer

Sherry Shen, MD;Bethina Liu, MD;Chad Fanti, MD;Maria Bromberg, MPH;Yuan Chen, PhD;Cassandra Chang;Neil M. Iyengar, MD
August 12th 2025
Article

Patients with breast cancer experience significant weight loss after using GLP-1 receptor agonists, highlighting potential benefits for obesity management in this population.